- Home
- BNTX vs GFS Comparison
BNTX vs GFS Comparison
Compare BNTX & GFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- GFS
- Stock Information
- Founded
- BNTX 2008
- GFS 2009
- Country
- BNTX Germany
- GFS United States
- Employees
- BNTX N/A
- GFS N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- GFS Semiconductors
- Sector
- BNTX Health Care
- GFS Technology
- Exchange
- BNTX Nasdaq
- GFS Nasdaq
- Market Cap
- BNTX 23.9B
- GFS 24.2B
- IPO Year
- BNTX 2019
- GFS 2021
- Fundamental
- Price
- BNTX $111.50
- GFS $42.39
- Analyst Decision
- BNTX Strong Buy
- GFS Buy
- Analyst Count
- BNTX 15
- GFS 15
- Target Price
- BNTX $143.50
- GFS $51.07
- AVG Volume (30 Days)
- BNTX 802.7K
- GFS 1.5M
- Earning Date
- BNTX 11-04-2024
- GFS 02-11-2025
- Dividend Yield
- BNTX N/A
- GFS N/A
- EPS Growth
- BNTX N/A
- GFS N/A
- EPS
- BNTX N/A
- GFS 1.32
- Revenue
- BNTX $3,390,698,192.00
- GFS $6,774,000,000.00
- Revenue This Year
- BNTX N/A
- GFS N/A
- Revenue Next Year
- BNTX N/A
- GFS $9.81
- P/E Ratio
- BNTX N/A
- GFS $32.12
- Revenue Growth
- BNTX N/A
- GFS N/A
- 52 Week Low
- BNTX $76.53
- GFS $35.85
- 52 Week High
- BNTX $131.49
- GFS $62.61
- Technical
- Relative Strength Index (RSI)
- BNTX 45.33
- GFS 45.04
- Support Level
- BNTX $112.91
- GFS $42.92
- Resistance Level
- BNTX $123.30
- GFS $44.60
- Average True Range (ATR)
- BNTX 4.70
- GFS 1.42
- MACD
- BNTX -0.62
- GFS -0.26
- Stochastic Oscillator
- BNTX 9.59
- GFS 4.70
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About GFS GlobalFoundries Inc.
GlobalFoundries is a top-five contract semiconductor manufacturer globally. It was originally the manufacturing arm of Advanced Micro Devices before it was spun out in 2009. The foundry sells chips into a range of end markets including smartphones, PCs, Internet of Things, data centers, automotive, industrial, and so on, but primarily focuses on more mature process technologies. Until 2021, the firm was privately held by Mubadala Investment, the sovereign wealth fund of the United Arab Emirates. GlobalFoundries merged with Chartered Semiconductor Manufacturing in 2009 and acquired IBM's chipmaking business in 2015. GF is headquartered in Malta, New York, and employs about 12,000 people.